Overview
- 93 inspections across 89 sites are on record.
- 184 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-11-21.
At a glance
Inspections
93
Sites
89
Observations
184
Career since
Nov 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Delta Pharma, Inc. | 21 Nov 2025 | Human Drugs | View 483 → |
| Pharmalogic Georgia LLC | 12 Sep 2025 | Human Drugs | |
| Choice All Natural Inc D | 26 Feb 2024 | Human Drugs | View 483 → |
| HUTCHMED (Suzhou) Limited | 4 Aug 2023 | Human Drugs | |
| Delta Pharma, Inc. | 2 Jun 2023 | Human Drugs | View 483 → |
Sites inspected
Delta Pharma, Inc.Ripley, United States2 insp.
Pharmalogic Georgia LLCAtlanta, United States1 insp.
Choice All Natural Inc DApex, United States1 insp.
HUTCHMED (Suzhou) LimitedSuzhou, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Ibad U Khan4 shared
Trang N Cox3 shared
Jared P Stevens2 shared
Veronica Fuentes2 shared
Jawaid Hamid2 shared
Bonita S Chester2 shared
Penny H Mccarver2 shared
Sheri S Oliver2 shared
Stephanie E Hubbard2 shared
Miaja Umaedi2 shared
Full investigator report
Get the verbatim findings behind Lareese K Thomas' 184 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site